2 recruiting, 2 withdrawn, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 2, Withdrawn 2, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow AdventHealth: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence 18F-rhPSMA-7.3 (Posluma) - Prostate Cancer (Post Prostatectomy) | Phase 2 | Recruiting | AdventHealth | 30 | 2024-09-20 | 2024-10-24 |
| Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery Nizaracianine Triflutate, Placebo Comparator - Injury of Ureter During Surgery (Disorder) | Phase 2 / Phase 3 | Recruiting | Curadel Surgical Innovations, Inc. | 336 | 2024-06-28 | 2026-02-23 |
| Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin - Metastatic Cancer, Urothelial Carcinoma | Phase 2 | Withdrawn | AdventHealth | 2023-05-08 | 2024-08-01 | |
| Stromal Vascular Fraction (SVF) Cells for Non-Operative Treatment of Small Rotator Cuff Tears Tisseel Injectable Product, Stromal Vascular Fraction Cells - Rotator Cuff Tears | Phase 2 | Withdrawn | AdventHealth | 2022-01-09 | 2023-02-15 | |
| Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia inhaled nitric oxide, Placebo - Pulmonary Hypertension, Bronchopulmonary Dysplasia | Phase 1 / Phase 2 | Terminated | AdventHealth | 32 | 2019-07-15 | 2025-01-15 |
Bronchopulmonary Dysplasia (1) · Carcinoma, Transitional Cell (1) · Hypertension, Pulmonary (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1) · Rotator Cuff Injuries (1)
Fibrin Tissue Adhesive (1) · PM 01183 (1) · Sugars (1) · ZW800-1 compound (1) · avelumab (1)
United States (5) · Netherlands (1)
Alexander L Vahrmeijer, M.D., Ph.D (1) · Hussnain Mirza, MD (1) · John V Frangioni, M.D., Ph.D. (1) · Tariq Awan, DO (1)